Cargando…

Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test”

Detalles Bibliográficos
Autores principales:	Weiland, Thomas, Brcic, Luka, Reinholz, Markus, French, Lars E., Thurnher, Dietmar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701314/ https://www.ncbi.nlm.nih.gov/pubmed/33254024 http://dx.doi.org/10.1016/j.ebiom.2020.103139

Ejemplares similares

DRH1 – a novel blood-based HPV tumour marker
por: Weiland, Thomas, et al.
Publicado: (2020)

Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
por: Waterboer, Tim, et al.
Publicado: (2020)

Unique Properties of Hepatocarcinogenesis-Resistant DRH Rat Hepatocytes Linked or Not Linked to the Drh1 Locus on Rat Chromosome 1
por: Hashimoto, Norikazu, et al.
Publicado: (2011)

Human Papillomavirus Type 16 L1 Serological Test Shows High Concordance with Anal Cytology in People Living with HIV
por: Ecke, Sara, et al.
Publicado: (2022)

DRH1, a p68-related RNA helicase gene, is required for chromosome breakage in Tetrahymena
por: McDaniel, Stephen L., et al.
Publicado: (2016)

Integration of scRNA-Seq and TCGA RNA-Seq to Analyze the Heterogeneity of HPV+ and HPV- Cervical Cancer Immune Cells and Establish Molecular Risk Models
por: Wei, Erdong, et al.
Publicado: (2022)

Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
por: Wessely, Anja, et al.
Publicado: (2020)

Mutation of the histidin residue of the DRH motif in vasopressin V2 receptor expression and function
por: Mir Mohammad Sadeghi, H., et al.
Publicado: (2010)

C. elegans Dicer acts with the RIG-I-like helicase DRH-1 and RDE-4 to cleave dsRNA
por: Consalvo, Claudia D., et al.
Publicado: (2023)

Reduced T Cell Response in Carcinogen‐sensitive Donryu Rats Compared with Carcinogen‐resistant DRH Rats
por: Mise‐Omata, Setsuko, et al.
Publicado: (1999)

Insights into the structure and RNA-binding specificity of Caenorhabditis elegans Dicer-related helicase 3 (DRH-3)
por: Li, Kuohan, et al.
Publicado: (2021)

Double-stranded RNA-dependent ATPase DRH-3: INSIGHT INTO ITS ROLE IN RNA SILENCING IN CAENORHABDITIS ELEGANS
por: Matranga, Christian, et al.
Publicado: (2010)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)

Quality of life and associated factors among family caregivers of individuals with psychiatric illness at DRH, South Wollo, Ethiopia, 2020
por: Gelaye, Habtam, et al.
Publicado: (2022)

A 5‑year update of patients with HPV positive versus negative oropharyngeal cancer after radiochemotherapy in Austria
por: Lill, Claudia, et al.
Publicado: (2017)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022)

Evaluation of hand hygiene and onset of hand eczema after the outbreak of SARS-CoV-2 in Munich
por: Kendziora, Benjamin, et al.
Publicado: (2021)

More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population
por: Marais, Dianne J, et al.
Publicado: (2006)

Identification of tumour-related proteins as potential screening markers by proteome analysis—protein profiles of human saliva as a predictive and prognostic tool
por: Krapfenbauer, Kurt, et al.
Publicado: (2014)

A bioinformatics approach for identifying the probable cause of the cross-interaction of antibodies to the antigenic protein HPV16 L1 with the HPV6 L1 protein
por: Stolbikov, A.S., et al.
Publicado: (2021)

HPV16 Impacts NHERF2 Expression in Oropharyngeal Cancers
por: Lulić, Lucija, et al.
Publicado: (2023)

Role of HPV16 E1 in cervical carcinogenesis
por: Baedyananda, Fern, et al.
Publicado: (2022)

Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes
por: Fontan, Christian T., et al.
Publicado: (2020)

The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology
por: Reinholz, Markus, et al.
Publicado: (2021)

Octenidine disinfection during the SARS-CoV-2 pandemia
por: Clanner-Engelshofen, Benjamin M., et al.
Publicado: (2021)

HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile
por: Lagos, Marcela, et al.
Publicado: (2015)

Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
por: Anderson, K S, et al.
Publicado: (2011)

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody
por: Peng, Shiwen, et al.
Publicado: (2021)

Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands
por: King, Audrey J., et al.
Publicado: (2016)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

A Live Vector Expressing HPV16 L1 Generates an Adjuvant-Induced Antibody Response In-vivo
por: Shirbaghaee, Zeinab, et al.
Publicado: (2015)

Antibodies against human papillomavirus type 16 (HPV-16) and conjunctival squamous cell neoplasia in Uganda
por: Waddell, K, et al.
Publicado: (2003)

Genetic Variability in L1 and L2 Genes of HPV-16 and HPV-58 in Southwest China
por: Yue, Yaofei, et al.
Publicado: (2013)

Correction: Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands
por: King, Audrey J., et al.
Publicado: (2016)

Longitudinal Dynamics of HPV16 Antibodies in Saliva and Serum among Pregnant Women
por: Pirttilä, Tiina, et al.
Publicado: (2022)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection
por: Monroy-García, Alberto, et al.
Publicado: (2011)

Anti-L1 antibody-bound HPV16 pseudovirus is degraded intracellularly via TRIM21/proteasomal pathway
por: Li, Meiying, et al.
Publicado: (2022)

The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10–16 years
por: Nakalembe, Miriam, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ei8at360sod3au06c5uqv11ur7